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In vitro cultures of human bone
marrow have been used to study normal
haemopoiesis and to gain information to
aid in the treatment ofleukaemia patients.
A workshop on the development of
semi-solid bone marrow cultures was held
for two days in Washington on 15 and 16
August 1976. The participants of this
workshop discussed some of the technical
problems associated with semi-solid cul-
tures of human marrow, and described
methods for obtaining reliable sources
of exogenous granulocyte macrophage
colony-stimulating factor (GM-CSF)* for
human cells. The following report was
compiled by the rapporteur from all the
oral presentations made at the workshop.
Bone marrow collection, preparation and
standardization
There are many critical procedures
which must be evaluated properly if
bone marrow colony assays are to be
used quantitatively. Human bone mar-
row specimens are invariably diluted to
a varying degree with peripheral blood
cells and no satisfactory method has
been devised to estimate the extent of
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this contamination. Since peripheral
blood contains few colony-forming cells
this tends to produce variable frequencies
of colony-forming cells (CFC)* in marrow
cultures. To minimize the amount of
peripheral blood, only cells from the
first part of the marrow specimen should
be used in the assay. When small bone
marrow samples are taken (e.g. 0-3 ml)
the cellularity of the specimen can in-
crease 2-3-fold, while the number of
CFC/105 nucleated cells appears to remain
constant. When using the semi-solid
culture system, both the marrow and
peripheral blood underlayer cells should
be washed free of heparin and autologous
plasma. The number of colonies grown
using this system with and without
autologous plasma is shown in Table I.
There is a linear relationship between
the number of nucleated cells plated
and the number of colonies observed,
provided that the number of cells is less
than 105/ml. If the cells are cultured
at a higher density, colonies are confluent
and it is difficult to avoid reaggregation
of cultured cells to form pseudo-colonies.
The optimal concentration of peripheral
blood leucocytes in feeder layers is
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* Several alternative abbreviations have been used to represent the progenitors of granulocyte and
macrophage colonies. There are differences in philosophy behind the various alternatives and no progress
was made towards the adoption of a uniform terminology. An attempt has been made to use a consistent
terminology throughout this report, but alternative names are widely used for CFC: in vitro CFC and
CFU-C. Similarly, granulocyte macrophage colony-stimulating factor (GM-CSF) is also referred to in
the literature as colony stimulating activity (CSA) and macrophage/granulocyte inducing factor (MGI).STANDARDIZATION OF CULTURES FOR NORMAL AND LEUKAEMIC CELLS 501
TABLE I.-Colonies Grown from Normal
Human Marrow Cells when Cultured
Over Washed and Unwashed Peripheral
Blood Leucocytes (Data of Robinson,
W. A., Etringer, M. and Bolin, Ift. A.,
University of Colorado)
Number of Range of Mean
Treatment of marrowst CFC/105 CFC/105
underlayer* tested cells cells
None 99 12-120 38
Washing 32 20-165 69
* Underlayers contained 106 cells.
t 2 x 105 marrow cells were cultured for 14 (lays
and aggregates of >40 cells scored as colonies.
106/ml, and better results are obtained
if the polymorphs are first removed from
the underlayer cells by density centrifuga-
tion over 1P070 g/cm3 bovine serum al-
bumin. Despite the differences in culture
techniques there was general agreement
that normal bone marrow cells contain
30-50 CFCs/105 cells. Several groups
reported that, although the frequency
ranged from 20 to 120 CFCs/105 on any
particular patient, the mean frequencies
all fell within the narrow range given
above.
Although many cultures are performed
with whole washed bone marrow cells,
it is often advantageous to fractionate
the cells before culture, e.g. if it is neces-
sary to culture the cells (a) free of colony-
stimulating cells or (b) free ofpolymorphs,
which appear to inhibit colony-stimulating
cells. The two most common procedures
for bone marrow cell fractionation relv
on cell density (to remove polymorphs
and some colony-stimulating cells) (Moore,
Williams and Metcalf, 1973; B0yum,
1968) and adherence properties (Messner,
Till and McCulloch, 1973; Lundgren,
Zukoski and Moller, 1968) to remove
colony-stimulating cells. The techniques
for cell fractionation do not appear
to be routine at present and many
technical differences exist between sepa-
rate laboratories (e.g. washing buffer,
osmolarity of solutions or speed of centri-
fugation). Consequently it is important
to document both the procedures used
and the overall recovery of cells from
these procedures. When normal marrow
was fractionated by either of these
techniques, the recovery of light-density
or non-adherent nucleated cells was ap-
proximately 5000 of the initial cell
number and the enrichment of CFCs was
1 5- to 2-fold.
At present there is no standard source
of CFCs available for the calibration
of the colony assay system. Although
bone marrow cells may be stored frozen,
the recovery of CFCs on thawing appears
to be extremely variable (10-60%O). Thus
it does not appear to be feasible to distri-
bute a standard source of bone marrow
cells. When reporting results for human
bone marrow assays, any technical details
which might help other laboratories to
repeat the published results should be
explained in the materials and methods
section of the report.
Semi-solid colony-forming assay
Several types of bone marrow colony-
forming assay are being used currently.
In many laboratories double layer cultures
are used, where peripheral blood leuco-
cytes are in an under-layer, to stimulate
bone marrow cells in a semi-solid over-
layer (Pike and Robinson, 1970; Entrin-
ger, Robinson and Kurnick, in press).
Other laboratories use a single semi-solid
layer containing both the bone marrow
cells and an exogenous GM-CSF stimulus
(Iscove et al., 1971; Prival et al., 1974).
Two supporting media (agar and methyl
cellulose) are used routinely. The results
in both systems depend on the quality
of all the reagents used in the culture
system, but in general the results are
comparable in the two assay systems.
Methyl cellulose may be preferable when
the experiment requires the harvesting
of colony cells, but the agar culture
system is essential when assessment of
cluster as well as colony numbers is
required (e.g. AML).
All the components of the CFC assay
system must be prepared carefully, andINTERNATIONAL CANCER RESEARCH WORKSHOP
checked to see that they support colony
growth. In particular it may be neces-
sary to screen several batches of foetal
calf serum before a batch supporting
acceptable levels of colony growth is
obtained. When using methyl cellulose
as the supporting medium, care should
be taken in dissolving the powder: the
semi-solid medium should be clear and
agranular. Incubators must control the
pH (,7.2), humidity and temperature
(37°C) accurately. The drying out of
the semisolid medium during the 7-14-day
cultures is a common problem in the
CFC assay system. This can be detected
by comparing the depth of the agar
layer with a freshly prepared plate.
Drying out can be minimized by checking
that the incubator is fully humidified.
When using methyl cellulose it is often
necessary to enclose 35-mm Petri dishes
inside a larger dish (60-mm) to avoid
drying out.
Reagents may be prepared sterile
or be rendered sterile by filtration. If
the latter method is used, it should be
noted that cellulose acetate filters some-
times contain detergent Which is in-
hibitory to colony growth.
Quantitation of CFCs
Colony or cluster formation may be
scored between 7 and 14 days and, al-
though there is no agreement as to the
number of cells which constitute colonies
or clusters, it is usually accepted that
colonies contain at least 20 cells, although
many laboratories only count colonies
with more than 40 cells. The results
of the CFC assay are dependent on the
definition of colonies and clusters and
the day on which the colonies are scored.
Exact methods of scoring should always
be stipulated in any publication. The
number of human colonies may be
maximal at Day 10, and colonies ap-
pearing after this time are not necessarily
generated from the same population of
precursor cells which generated the initial
colonies. When colonies are scored for
the morphology of the component cells
(eosinophil, neutrophil or macrophage),
it is apparent that the relative frequency
of eosinophil colonies increases with the
age of the culture (Table II). These
considerations can be important when
analysing results from density-gradient
or sedimentation-velocity analysis of CFC
populations.
TABLE II.-Colony (>50 Cells) and Clus-
ter (5-49 Cells) Morphology in Normal
Human Bone Marrow Cultures (105
Cells) Stimulated with GM-CSF from
Human Placenta-conditioned Medium
(Data of Dresch, C. and Mletcalf, D.,
Walter and Eliza Hall Institute of
Medical Research, Melbourne)
Colonies/105 cells Clusters/105 cells
A A
Day of Eosino- Neutrophil Eosino- Neutrophil
scoring phil monocyte phil monocyte
7 0*4 16 61 155
10 3 27 67 126
14 11 33 56 107
It is essential when attempting to
measure CFC levels in cell populations
that the GM-CSF concentration is high
enough to stimulate all the CFCs present.
Many conditioned media used in the
past have not delivered a maximal
stimulus, although good peripheral blood
underlayers seem capable of maximal
stimulation. Human embryo kidney and
human placental GM-CSF concentrates
have been prepared which appear to
stimulate maximal colony growth over a
10-fold concentration range. Although
the maximal number of colonies stimulat-
ed with these conditioned media appears
to be slightly higher than peripheral
blood underlayers, the colony size is
not as large. When suboptimal concen-
trations of GM-CSF are used, it is difficult
to obtain results which are dependent
only on the CFC levels in the sample.
Quantitation of GM-CSF
When measuring GM-CSF concentra-
tions, care should be taken to subtract
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background colonies (especially when more
than 105 bone marrow cells are plated)
and to titrate the sample, in case inhibitors
are present. Three laboratories have
titrated an identical sample of human
embryo kidney GM-CSF, and similar
titration curves were found in each of
the laboratories, even though the absolute
numbers of colonies differed widely (Table
III). Many serum and urine samples
contain inhibitors, and it is difficult to
obtain accurate levels of GM-CSF unless
these are actually removed by precipita-
tion or chromatography.
TABLE III.-Titration of Human Embryo
Kidney GM-CSF Concentrate (Abbott
Pty Ltd, North Chicago) on 2 x 105
Non-Adherent Human Bone Marrow
Cells. Colonies (>20 cells) were Scored
Between 10 and 14 Days
Number of colonies/105 cells
Dilution of , _ _ _ _
GM-CSF Toronto* Pittsburght Bethesdat
1/200 2 35 10
1/1000 25 61 42
1/2000 47 20
1/3000 12 - -
* E. A. McCulloch, Ontario Cancer Institute.
t P. A. Chervenick, University of Pittsburgh.
t J. M. Bull, National Cancer Institute.
Sources of GM-CSF
(1) Feederlayers. Peripheral blood
leucocytes from monkeys or humans may
be used as underlayers to stimulate
colony growth from human CFC (Pike
and Robinson, 1970). Leucocyte under-
layers provide excellent stimulation of
CFC, but are not reliable in a quantitative
sense. Often the underlayers are inactive
and the level of stimulation is dependent
on the method of storing the underlayers.
When leucocyte underlayers are used
to provide the exogenous source of CSF
more than one batch of underlayers
should be used, and the results of the
most active underlayer used. Although
underlayers may be stored at 37°C in
a fully humidified atmosphere of 10%
CO2 in air for almost 2 weeks before use
in a CFC assay, after the first week the
incidence of inactive underlayers in-
creases.
Attempts have been made to prepare
conditioned medium which will stimulate
growth from human bone marrow cells.
Conditioned medium from peripheral
blood leucocytes, phytohaemagglutinin
(PHA)-stimulated lymphocytes, human
embryo kidneys, human monocyte macro-
phages, human placentas and monkey
lungs will all induce colony formation
from human bone marrow, but none of
these sources will stimulate maximal
numbers of colonies unless they are
concentrated. In general, the concen-
trated conditioned media stimulate a
similar number of colonies to peripheral
blood underlayers, but the size of the
colonies is invariably smaller with condi-
tioned media.
(2) Conditioned media.-(a) Peripheral
blood leucocytes: Prepared directly from
human peripheral blood leucocytes (Iscove
et al., 1971) or by using PHA to stimulate
the leucocytes or lymphocytes (Prival et
al., 1974).
(b) Human embryo kidney: Prepared
by Abbott Pty Ltd, North Chicago,
U.S.A., under contract to NCI, from
medium conditioned by human embryo
kidney slices (Brown and Carbone, 1971).
This conditioned medium has been con-
centrated and partially purified by gel-
filtration chromatography. Human kid-
ney cell tissue culture harvests (160 1)
were treated with an ion exchange resin
(to remove urokinase) and concentrated
at pH 8*0 by ultrafiltration over a UM-10
membrane (3.2 ft2 surface area) to a
protein concentration of 200 mg/ml. After
clarification by centrifugation, 400 ml of
the concentrate wasfractionated on Sepha-
dex G-75 (20 x 120 cm) using tris-HCl
(0-01 M, pH 7.4), EDTA (1 mM) and
trichlorobutanol (0.1%) as the eluting
buffer. The protein eluting between 29 1
and 33 1 was concentrated by ultra-
filtration on a UM-2 membrane to a
protein concentration of 250-350 mg/ml
and stored frozen. Several laboratoriesINTERNATIONAL CANCER RESEARCH WORKSHOP
have tested the concentrated conditioned
medium and have confirmed its usefulness
as a reliable source of GM-CSF for the
stimulation of human marrow cells. At
a dilution of 1/1000 this preparation
appears to stimulate maximally both
normal and leukaemic cells. Much of
this conditioned medium is being set
aside for its potential clinical use. Pre-
liminary arrangements are being made
for pyrogen and toxicity tests, so that
Phase I clinical trials may be performed
on leukaemic or anaemic patients in the
near future.
(c) Human monocyte macrophage: Pre-
pared from monolayer cultures initiated
from humanperipheral blood cells (M. A. S.
Moore, personal communication). This
conditioned medium contains GM-CSFs
which will stimulate both mouse and
human CFC. The mouse and human
GM-CSF appear to be produced at
different times-after a week in culture
human GM-CSF is no longer produced.
The mouse GM-CSF appears to have
mol. wt of 90,000 and the human GM-CSF
a mol. wt of 30,000.
(d) Human placenta: Prepared by cul-
turing placental pieces in vitro (Burgess,
Wilson and Metcalf, 1977). The human
placentas used in this study were stored at
4°C and used within 12h ofdelivery. The
outer membranes were removed and the
placental tissue cut into 5-mm3 pieces.
After being rinsed x 3 in Eisen's Balanced
Salt Solution, 6 pieces were cultured in
RPMI-1640 (Gibco, Grand Island, New
York) containing 5% foetal calf serum
(20 ml). The cultures were incubated
for 7 days and the conditioned medium
was harvested by filtering through a
double layer of cotton gauge and centri-
fugation at 10,000 g for 20 min. Un-
treated placenta-conditioned medium con-
tained inhibitory material, and the levels
ofinhibitory material appeared to increase
with continued incubation beyond 7
days.
HPCM (41) was dialysed against
distilled water and treated with calcium
phosphate gel. Most of the protein,
including the GM-CSF, bound to the
gel within 2 h and the supernatant fluid
was removed by decantation. GM-CSF
was eluted from the gel with 0 05 M
sodium phosphate buffer, pH 6-8 (2 x 250
ml). The two eluates were pooled and
concentrated 12-fold, either by using
ultrafiltration or by absorption on to
and elution from DEAE-cellulose. Hu-
man placental GM-CSF, concentrated in
this way, maximally stimulated human
bone marrow cells at dilutions from 1/1
to 1/10.
Availability of human GM-CSF prepara-
tions
Small amounts of GM-CSF concen-
trates from human embryo kidney- and
human placenta-conditioned medium are
available for distribution to interested
laboratories. It is intended to establish
a reference source of GM-CSF for human
bone marrow cells. The results from
the use of these concentrates will be
pooled and evaluated at a future work-
shop. Laboratories wishing to obtain a
sample ofthe concentrates should address
their enquiries to Dr J. M. Bull, National
Cancer Institute, National Institutes of
Health, Bethesda, Maryland, 20014, U.S.A
Cell-cell interaction in bone marrow cultures
Bone marrow cells contain several
subpopulations of cells which affect the
growth of CFC colonies. One subpopula-
tion produces GM-CSF and will support
the spontaneous proliferation of CFC
when the cell density is greater than
2 X 105/ml. Another subpopulation pro-
duces an inhibitor which acts on the
GM-CSF-producing cells but not on the
CFC. This inhibitory material may be
prepared from granulocytes, and is non-
dialysable and heat-labile (Broxmeyer,
Moore and Ralph, 1976). The inhibitor
is not toxic to CFC, and appears to act
reversibly on the GM-CSF-producing cells.
This inhibitor will inhibit colony growth
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due to endogenous production of GM-
CSF (e.g. at high cell density), but does
not affect colony growth induced by
exogenous sources of GM-CSF.
Purification and properties of GM-CSF
Progress has been made recently in
the purification of GM-CSF from serum-
free mouse L-cell-conditioned medium
(Stanley et al., 1976). Although this
GM-CSF is not active on human bone
marrow, the principles outlined in its
purification should prove useful for the
characterization of human GM-CSFs.
When preparing mouse L-cell-condi-
tioned medium it is important to ensure
that the cells remain adherent during
the 7-day culture period, and that the
total cell number increases four-fold.
Variation in the culture conditions leads
to different molecular variants of GM-
CSF. The purified molecule appears to
be a glycoprotein (mol. wt 65,000), which
binds to concanavalin A-Sepharose. The
molecule appears to break down into
inactive subunits (mol. wt 35,000) in
the presence of reducing agents such
as mercapto-ethanol. GM-CSF is lost
from solution at low protein concentra-
tions (<1 mg/ml), unless agents such
as polyethylene glycol or Triton-X 100
are present.
The initial purification steps involve
dialysis and concentration of the mouse
L-cell-conditioned medium (5-101) by
rotary evaporation, followed by DEAE-
cellulose chromatography and gel filtra-
tion on Sephadex G-200, where most
of the GM-CSF eluted with an apparent
mol. wt of 120,000, but there was some
colony-stimulating activitv which eluted
with a mol. wt of ,40,000. Although
most of the semi-purified GM-CSF binds
to a concanavalin A-Sepharose affinity
column, a small amount (<15%) did
not interact with this lectin. The pro-
portion of the GM-CSF bound was de-
pendent on the culture conditions used
to prepare the L-cell-conditioned medium.
After concanavalin A-Sepharose chroma-
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tography, GM-CSF eluted from Sephadex
G-200 as a single peak mol. wt of 65,000.
Thus, the apparent mol. wt of partially
purified GM-CSF may be affected by
the binding of GM-CSF to other proteins.
To conserve GM-CSF, and to detect
the low amounts of protein involved in
further purification steps, a small pro-
portion of the GM-CSF preparation may
be radioiodinated and mixed back into
the partially purified material from the
affinity chromatography (Stanley et al.,
1975). The final purification step, poly-
acrylamide gradient (4-25%) gel electro-
phoresis, allows the GM-CSF to be
isolated from all the other proteins.
Approximately 80 ,ug of pure GM-CSF,
representing a 20% recovery of the
initial activity, was recovered from the
gradient-gel electrophoresis. The specific
activity of pure mouse L-cell-conditioned
medium GM-CSF was 3 x 108 colonies/mg
of protein. The purity of the protein
was analysed by discontinued polyacryl-
amide-gel electrophoresis in both the
presence and absence of sodium dodecyl
sulphate. A single protein band was
observed, and this was associated with
all the GM-CSF activity. Isoelectric fo-
cusing (pH 3-8) indicated some charge
heterogeneity, but CSA was associated
with all protein species.
Human bone marrow can be stim-
ulatedbyPHA-leucocyte- orPHA-lympho-
cyte-conditioned medium. W"hen human
leucocytes are stimulated by PHA, GM-
CSFs active in both mouse and human
cells are produced, whereas medium
from PHA-stimulated lymphocytes only
stimulated human colony formation
(Prival et al., 1974). Preliminary frac-
tionation of GM-CSFPHA-Ly indicated
that there were several molecular species.
After precipitation by ammonium sul-
phate, gel filtration on Sephadex G-150
showed two GM-CSF peaks, at mol. wt
17,000 and 33,000. Chromatography on
DEAE-cellulose separated the lower mol.
wt GM-CSF into two peaks. Similarly,
concanavalin A-Sepharose chromato-
graphy of the higher mol. wt GM-CSFINTERNATIONAL CANCER RESEARCH WORKSHOP
indicated that only a small amount of
this GM-CSF contained the appropriate
carbohydrate moieties to bind to the
column, most of the GM-CSF eluting at
the void volume. PHA-stimulated lym-
phocyte-conditioned medium supports the
proliferation of normal bone marrow
cells in liquid culture. After a few
days, CFC are lost from these cultures,
but " lymphocytic " cells continue to
proliferate for many months (Morgan,
Ruscetti and Gallo, 1976). The factor
responsible for proliferation of a sub-
population of cells from normal bone
marrow binds to concanavalin A-Sepha-
rose.
The preparation of (M-CSF from
medium conditioned by human embryo
kidney cells has been undertaken on a
large scale by Abbott Industries. Con-
ditioned medium (150-2501) is concen-
trated by ultrafiltration and chromato-
graphed on Sephadex G-75 (mol. wt
33,000). The peak of GM-CSF activity
eluted after the bulk of the protein, and
was concentrated by ultrafiltration for
use as a standard reagent.
Human placenta-conditioned medium
GM-CSF was concentrated by absorption
on to calcium phosphate gel and subse-
quent ultrafiltration. Further purifica-
tion has been achieved by DEAE-cellulose
and Sephadex G-150 chromatography.
Only one peak of GM-CSF activity was
detected in these systems, and the mol. wt
from the gel-filtration column was
r30,000. Further purification was
achieved by polyacrylamide-gel electro-
phoresis at pH 8-4, where the GM-CSF
separated from most of the other conxi-
ponents, and could be eluted with a
specific activity of 1 6 x 105 colonies/mg
protein. GM-CSF from human placenta-
conditioned medium does not appear to
bind to concanavalin A-Sepharose.
Culture systemsfor leukaemia cells
Bone marrow and peripheral blood
cells from AML patients do not usually
form colonies in the semi-solid CFC
assay, although in the presence of an
exogenous source of GM-CSF some AML
cells proliferate to form clusters of 5-30
cells. It was reported recently that an
overnight incubation in liquid culture
with PHA will stimulate the leukaemic
cells to develop colonies in a subsequent
semi-solid clonal assay (Dicke, Spitzer
and Ahearn, 1976). After preparation
of the bone marrow cell suspension,
8 x 106 cells were added to 4 ml of
Alpha or Dulbecco's medium containing
foetal calf serum (10%) and horse serum
(10%) and divided equally between two
tissue culture tubes. PHA (Wellcome)
was added at 8 ,ug/ml to one tube and
the other tube was kept as a control. The
tubes were incubated for 15-20 h at
37°C in a fully humidified atmosphere
of 50o CO2. After this incubation, the
last wash was with Alpha or Dulbecco's
single strength medium containing foetal
calf serum (100o) and horse serum (10%).
After the last wash, the cells were brought
up to 1 ml and counted. A fixed volume
of cells (0-175 ml) was added to 7 ml of
the same medium containing agar (0-3%/)
and 1-ml cultures were plated on each
of 3 leucocyte underlayers and 3 under-
layers without leucocytes (in 0 5% 0 agar).
Immediately after plating, the aggrega-
tion was scored in 1/10 of a plate, the
number and size of the clumps being
recorded. Usually the size of the ag-
glutinate is 3-10 cells and the number
varies from 0 to 200 agglutinates per
dish. Plates with agglutination are dis-
carded and the others incubated for
7 days, and after that period the colonies
and clusters are counted. A colony is
considered as a cell aggregate containing
50 cells or more. Colony formation after
PHA pretreatment is not influenced
by GM-CSF. Normal bone marrow cells
also form colonies after pretreatment
with PHA, but only in the presence of
GM-CSF. The semi-solid agar cultures
contain horse serum, which suppresses
the formation of PHA-stimulated lym-
phoid colonies (Rosenszajn et al., 1975).
The major problem with the current
assay procedure is the agglutination of
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the white cells during the overnight
liquid culture. The cells must be dis-
persed very gently but thoroughly, before
preparing the agar plates. If there are
many small aggregates in the agar the
cultures are discarded, because it is
subsequently difficult to interpret the
plates. Although the formation of colo-
nies from PHA-treated AML cells is not
dependent on an exogenous source of
GM-CSF, some enhancement in colony
growth occurs in the presence of medium
conditioned with PHA-treated lympho-
cytes.
The activation of AML cells by PHA
is dependent on the density of cells in
the preincubation, suggesting that cell-
cell interaction is involved in the activa-
tion of leukaemia CFCs. Once the cells
are placed in agar, there is a linear
relationship between the number of cells
plated and the number of colonies which
appear at 14 days.
Although the bone marrow of most
patients forms colonies or clusters in
the semi-solid clonal assay, there are
some patients who show little or no
colony growth. One particular patient,
described by N. Testa, appeared to have
normal bone marrow and peripheral blood
differentials, but presented with thrombo-
cvtopenia. Bone marrow colony assays
failed to detect CFC in this patient
(Milner et al., 1977). Mixing experiments
with normal human marrow indicated
that the failure to grow was not due to
inhibitor cells. When used as feeder
layers, this patient's bone marrow and
peripheral blood cells stimulated colony
formation in normal human bone marrow
cultures. Thus the cells from this patient
appeared to be capable of producing
normal levels of GM-CSF. Although the
CFC assay has been useful for our under-
standing of proliferation and differentia-
tion in the haemopoietic system, there
are still cases where patients have normal
granulocyte-macrophage levels but no
detectable CFC's. This suggests that
granulopoiesis is not regulated only by
the GM-CSF produced by normal bone
35*
marrow or peripheral blood cells in
vitro, and that granulopoiesis in the in
vitro colony assay is not necessarily a
quantitative indication of granulopoiesis
in vivo .
Recently a new colony assay has
been devised, based upon studies of the
proliferation of leukaemic blast cells in
suspension culture. Stimulation of pro-
liferation is observed in cultures contain-
ing media conditioned by normal or
leukaemic leucocytes in the presence
of PHA (Aye et al., 1974. Based on this
observation, PHA-LCM was tested for its
capacity to promote colony formation by
cells from the peripheral blood ofpatients
with AML or CML. Colony formation
was observed: the colonies contain per-
oxidase-negative cells and appear to be
different from colonies formed by the
proliferation of granulopoietic progeni-
tors. For example, colony formation by
leukaemic peripheral blood is not stimu-
lated by conventional leucocyte-condi-
tioned media (active as stimulators of
granulopoiesis). Nor is it, at present
possible to obtain colonies from marrow
similar to those observed in cultures of
leukaemic peripheral blood. The active
molecules in PHA-LCM appear to be
different from granulopoietic progenitors.
Preliminary separation on Sephadex 150
indicates a mol. wt of 44,000. This
molecular species can be dissociated by
2-mercaptoethanol into 27,000 and 15,000
mol. wt moieties. In some PHA-LCM pre-
parations, the 27,000 mol. wt is found by
itself, without the larger molecularspecies.
At very high concentrations of PHA-
LCM (500o v/v) colony formation is
observed by cells from the peripheral
blood. The cells in such colonies are
morphologically different from those ob-
tained from leukaemic blood, and have
the appearance of small lymphocytes.
Further, they are capable of E-rosette
formation. The relationship, if any, of
the stimulator of such colonies to the
stimulator of colonies from leukaemic
blasts has not been established.
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different classes of progenitors have been
detected in human marrow and peripheral
blood, which include progenitors ofgranu-
locytes and macrophages, progenitors of
lymphocytes, both B (Fibach et al.,
1976) and T (Rozenszajn et al., 1975) and
yet undefined progenitors in leukaemic
peripheral blood. The lineage relation-
ships between these cells have not yet
been determined. Collaboration between
several laboratories is now under way
in order to compare different stimulators
in a series of standardized cultural
conditions.
This workshop was supported in part
by a grant from the International Cancer
Research Data Bank of the United
States of America, administered by the
International Union Against Cancer.
REFERENCES
AYE, M. T., NIHO, Y., TILL, J. E. & MCCULLOCH,
E. A. (1974) Studies of Leukemic Cell Populations
in Culture. Blood, 44, 205.
B0YUM, A. (1968) Separation of Leukocytes from
Blood and Bone Marrow. Scand. J. clin. Lab.
Invest., 21 (Suppl. 97).
BROWN, C. H. & CARBONE, P. P. (1971) In Vitro
Growth of Normal and Leukemic Human Bone
Marrow. J. natn. Cancer Inst., 46, 989.
BROXMEYER, H. E., MOORE, M. A. S. & RALPH, P.
(1976) Cell-free Granulocyte Inhibiting Activity
Derived from Human Polymorphonuclear Neutro-
phils (in press).
BuRGEss, A. W., WILSON, E. M. A. & METCALF, D.
(1977) Stimulation by Human Placental Condi-
tioned Medium of Hemopoietic Colony Formation
by Human Marrow Cells. Blood (in press).
DICKE, K. A., SPITZER, G. & AHEARN, M. J. (1976)
Colony Formation in vitro by Leukaemic Cells
in Acute Myelogenous Leukaemia with Phyto-
haemagglutinin as Stimulating Factor. Nature,
Lond., 259, 129.
ENTRINGER, M. A., ROBINSON, W. A. & KURNICK, J.
(1976) J. exp. Hematology, in press.
FIBACH, E., GERASSI, E. & SACHS, L. (1976) Indica-
tion of Colony Formation in vitro by Human
Lymphocytes. Nature, Lond., 259, 127.
ISCOVE, N. N., SENN, J. S., TILL, J. E. & MCCUL-
LOCH, E. A. (1971) Colony Formation by Normal
and Leukemic Human Marrow Cells in Culture:
Effect of Conditionedl Medium from Humau
Leukocytes. Blood, 37, 1.
LUNDGREN, G., ZUKOSKI, C. M. F. & MOLLER, G.
(1968) Differential Effects of Human Granulo-
cytes and Lymphocytes on Human Fibroblasts
in vitro. Clin. exp. Immunol., 3, 817.
MILNER, G. R., TESTA, N. G., GEARY, C. G., DEXTER,
T. M., MIJLDAL, S., MACIVER, J. E. & LAJTHA,
L. G. (1977) Bone Marrow Culture Studies in
Refractory Cytopenia and Smouldering Leuk-
aemia. Br. J. Haemat. (in press).
MESSNER, H. A., TILL, J. E. & MCCULLOCH, E. A.
(1973) Interacting Cell Populations Affecting
Colony Formation by Normal and Leukemic
Human Marrow Cells. Blood, 42, 701.
MOORE, M. A. S., WILLIAMS, N. & METCALFE, D.
(1973) In Vitro Colony Formation by Normal
and Leukemic Hematopoietic Cells: Charac-
terization of Colony Forming Cells. J. natn.
Cancer Inst., 50, 603.
MORGAN, D. A., RUSCETTI, F. W. & GALLO, R
(1976) Selective in vitro Growth of T-Lympho-
cytes from Normal Human Bone Marrows.
Science, N.Y., 193, 1007.
PIKE, B. L. & ROBINSON, W. A. (1970) Human
Bone Marrow Colony Growth in Agar-Gel.
J. cell. Physiol., 76, 77.
PRIVAL, J. T., PARAN, M., GALLO, R. C. & WIJ,
A. M. (1974) Colony Stimulating Factors in
Cultures of Human Peripheral Blood Cells.
J. natn. Cancer Inst., 53, 1583.
ROSENSZAJN, L. A., SHOHAM, D. & KALECHMAN, I.
(1975) Clonal Proliferation of PHA-stimulated
Human Lymphocytes in Soft Agar Culture.
Immunology, 29, 1041.
STANLEY, E. R., CIFONE, M., HEARD, P. M. &
DEFENDI, V. (1976) Factors Regulating Macro-
phage Production and Growth: Identity of
Colony-Stimulating Factor and Macrophage
Growth Factor. J. exp. Med., 143, 631.
STANLEY, E. R., HANSON, G., WooDcocK, J. &
METCALF, D. (1975) Colony Stimulating Factor
and the Regulation of Granulopoiesis and Macro-
phage Production. Fed. Proc., 34, 2272.